Chemokines and Chemokine Receptors Blockers as New Drugs for the Treatment of Chronic Obstructive Pulmonary Disease

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|20|35|4317-4349

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.20, Iss.35, 2013-11, pp. : 4317-4349

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Chemokine Receptors in Chronic Obstructive Pulmonary Disease (COPD)

By  

Current Drug Targets, Vol. 7, Iss. 6, 2006-06 ,pp. : 669-674

Bentham Science Publishers

Access to resources Recommend Favorite

CC-Chemokine Receptors in Chronic Obstructive Pulmonary Disease

By  

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 6, Iss. 2, 2007-06 ,pp. : 75-79

Bentham Science Publishers

Access to resources Recommend Favorite

Chemokines and Their Receptors in Chronic Pulmonary Disease

By  

Current Drug Targets. Inflammation & Allergy, Vol. 4, Iss. 3, 2005-01 ,pp. : 313-317

Bentham Science Publishers

Access to resources Recommend Favorite

Potential new drugs for therapy of chronic obstructive pulmonary disease

By de Boer WI  

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 7, 2003-07 ,pp. : 1067-1086

Informa Healthcare

Access to resources Recommend Favorite

Economic Burden of Chronic Obstructive Pulmonary Disease: Impact of New Treatment Options

By Friedman M.  

PharmacoEconomics, Vol. 19, Iss. 3, 2001-03 ,pp. : 245-254

Adis International

Access to resources Recommend Favorite